Seronegative generalized myasthenia gravis: Clinical features, antibodies and their targets
VINCENT A, BOWEN J, NEWSOM-DAVIS J, MCCONVILLE J. Seronegative generalized myasthenia gravis: clinical features, antibodies and their targets. Lancet Neurol 2003;2:99-106.
Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis
EVOLI A, TONALI PA, PADUA L et al. Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis. Brain 2003;126:2304-11.
Detection and characterization of MuSK antibodies in seronegative myasthenia gravis
MCCORVILLE J, FARUGIA ME, BEESON D et al. Detection and characterization of MuSK antibodies in seronegative myasthenia gravis. Ann Neurol 2004;55:580-4.
Patterns and severity of neuromuscular transmission failure in seronegative myasthenia gravis
NEMOTO Y, KUWABARA S, MISAWA S et al. Patterns and severity of neuromuscular transmission failure in seronegative myasthenia gravis. J Neurol Neurosurg Psychiatry 2005;76:714-8.
Stimulated single-fiber EMG of the frontalis and orbicularis oculi muscles in ocular myasthenia gravis
VALLS-CANALS J, PODEDANO M, MONTERO J, PRADAS J. Stimulated single-fiber EMG of the frontalis and orbicularis oculi muscles in ocular myasthenia gravis. Muscle Nerve 2003;28:501-3.
The study of normal and abnormal neuromuscular transmission with single fibre electromyography
STÅLBERG E, TRONTELJ JV. The study of normal and abnormal neuromuscular transmission with single fibre electromyography. J Neurosci Methods 1997;74:145-54.
Mechanisms of fatigue in normal intercostals muscle and muscle from patients with myasthenia gravis
PAGALA M, NANDAKUMAR NV, VENKATACHARI SAT, RAVINDRAN K, AMALADEVI B, GROB D. Mechanisms of fatigue in normal intercostals muscle and muscle from patients with myasthenia gravis. Muscle Nerve 1993;16:911-21.